Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward

Get the Details Now.

DNLI Insider Trading (Denali Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $19,158,188.07

Denali Therapeutics Insider Trading History Chart

Denali Therapeutics Share Price & Price History

^$24.72

▲ +0.95 (4.00%)

As of 05/20/2022 01:00 AM ET

Days: 30 | 90 | 365

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

Denali Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$33.83	$676,600.00
2/11/2022	Alexander O Schuth	COO	Sell	2,803	$34.68	$97,208.04
2/11/2022	Carole Ho	Insider	Sell	2,918	$34.71	$101,283.78
2/11/2022	Ryan J Watts	CEO	Sell	9,491	$34.72	$329,527.52
2/11/2022	Steve E Krognes	CFO	Sell	2,560	$34.69	$88,806.40
2/9/2022	Alexander O Schuth	COO	Sell	1,423	$37.10	$52,793.30
2/9/2022	Ryan J Watts	CEO	Sell	2,719	$37.55	$102,098.45
2/9/2022	Steve E Krognes	CFO	Sell	1,296	$37.09	$48,068.64
1/5/2022	Alexander O Schuth	COO	Sell	2,846	$44.77	$127,415.42
1/5/2022	Carole Ho	Insider	Sell	2,845	$44.78	$127,399.10
1/5/2022	Ryan J Watts	CEO	Sell	5,007	$44.78	$224,213.46
1/5/2022	Steve E Krognes	CFO	Sell	2,225	$44.75	$99,568.75
12/30/2021	Marc Tessier-Lavigne	Director	Sell	20,047	$45.36	$909,331.92
12/28/2021	Marc Tessier-Lavigne	Director	Sell	10,980	$44.37	$487,182.60
12/6/2021	Alexander O Schuth	COO	Sell	10,000	$42.27	$422,700.00
12/6/2021	Carole Ho	Insider	Sell	1,476	$42.52	$62,759.52
12/1/2021	Ryan J Watts	CEO	Sell	18,333	$44.92	$823,518.36
11/10/2021	Vicki L. Sato	Director	Sell	1,666	$52.81	$87,981.46
11/4/2021	Alexander O Schuth	COO	Sell	10,000	$52.84	$528,400.00
10/4/2021	Alexander O Schuth	COO	Sell	10,000	$50.56	$505,600.00
9/15/2021	Vicki L. Sato	Director	Sell	1,666	$53.40	$88,964.40
9/7/2021	Alexander O Schuth	COO	Sell	10,000	$55.55	$555,500.00
9/1/2021	Ryan J. Watts	CEO	Sell	18,333	$54.66	$1,002,081.78
8/23/2021	Carole Ho	Insider	Sell	6,143	$48.91	$300,454.13
8/19/2021	Alexander O Schuth	COO	Sell	2,544	$49.60	$126,182.40
8/19/2021	Carole Ho	Insider	Sell	2,546	$49.58	$126,230.68
8/19/2021	Ryan J Watts	CEO	Sell	2,376	$49.57	$117,778.32
8/19/2021	Steve E. Krognes	CFO	Sell	2,285	$49.57	$113,267.45
8/18/2021	Vicki L. Sato	Director	Sell	1,666	$51.70	$86,132.20
8/4/2021	Alexander O Schuth	COO	Sell	10,000	$52.22	$522,200.00
8/2/2021	Ryan J Watts	CEO	Sell	18,333	$51.41	$942,499.53
7/21/2021	Vicki L. Sato	Director	Sell	1,666	$65.13	$108,506.58
6/23/2021	Vicki L. Sato	Director	Sell	1,666	$70.74	$117,852.84
6/7/2021	Marc Tessier-Lavigne	Director	Sell	94,378	$70.35	$6,639,492.30
6/4/2021	Alexander O. Schuth	COO	Sell	10,000	$64.55	$645,500.00
6/1/2021	Ryan J. Watts	CEO	Sell	18,333	$61.40	$1,125,646.20
5/26/2021	Vicki L. Sato	Director	Sell	1,666	$65.37	$108,906.42
5/24/2021	Marc Tessier-Lavigne	Director	Sell	8,806	$60.02	$528,536.12
5/21/2021	Marc Tessier-Lavigne	Director	Sell	37,957	$60.13	$2,282,354.41
5/4/2021	Alexander O. Schuth	COO	Sell	10,000	$55.49	$554,900.00
4/28/2021	Vicki L. Sato	Director	Sell	1,666	$62.15	$103,541.90
4/5/2021	Alexander O. Schuth	COO	Sell	10,000	$56.09	$560,900.00
4/1/2021	Marc Tessier-Lavigne	Director	Sell	50,000	$56.62	$2,831,000.00
4/1/2021	Ryan J. Watts	CEO	Sell	18,334	$56.60	$1,037,704.40
3/29/2021	Carole Ho	Insider	Sell	2,822	$54.62	$154,137.64
3/15/2021	Steve E. Krognes	CFO	Sell	50,000	$61.89	$3,094,500.00
3/4/2021	Alexander O. Schuth	COO	Sell	10,000	$61.02	$610,200.00
3/3/2021	Vicki L. Sato	Director	Sell	1,666	$61.61	$102,642.26
2/16/2021	Steve E. Krognes	CFO	Sell	50,000	$65.09	$3,254,500.00
2/12/2021	Douglas K Bratton	Major Shareholder	Sell	2,216,798	$65.00	$144,091,870.00
2/11/2021	Alexander O. Schuth	COO	Sell	3,047	$70.35	$214,356.45
2/11/2021	Carole Ho	Insider	Sell	3,156	$70.33	$221,961.48
2/11/2021	Ryan J. Watts	CEO	Sell	9,473	$70.30	$665,951.90
2/11/2021	Steve E. Krognes	CFO	Sell	3,035	$70.34	$213,481.90
2/9/2021	Alexander O Schuth	COO	Sell	1,468	$74.80	$109,806.40	10,686
2/9/2021	Carole Ho	Insider	Sell	1,470	$74.68	$109,779.60	1,476
2/9/2021	Ryan J Watts	CEO	Sell	5,112	$73.79	$377,214.48
2/9/2021	Steve E Krognes	CFO	Sell	1,448	$74.68	$108,136.64	14,427
2/4/2021	Alexander O Schuth	COO	Sell	10,000	$67.84	$678,400.00	10,686
2/1/2021	Ryan J Watts	CEO	Sell	18,334	$68.44	$1,254,778.96
1/15/2021	Steve E Krognes	CFO	Sell	50,000	$71.45	$3,572,500.00	10,177
1/4/2021	Alexander O Schuth	COO	Sell	70,000	$74.95	$5,246,500.00	10,686
1/4/2021	Ryan J Watts	CEO	Sell	88,334	$74.96	$6,621,516.64
12/21/2020	David P. Schenkein	Director	Sell	25,000	$90.06	$2,251,500.00
12/14/2020	Douglas K Bratton	Major Shareholder	Sell	17,825	$80.38	$1,432,773.50
12/11/2020	Douglas K Bratton	Major Shareholder	Sell	46,799	$80.05	$3,746,259.95
11/12/2020	David P Schenkein	Director	Sell	30,000	$70.05	$2,101,500.00	25,000
11/4/2020	David P Schenkein	Director	Sell	10,000	$50.18	$501,800.00	65,000
10/9/2020	Carole Ho	Insider	Sell	30,000	$41.22	$1,236,600.00
9/10/2020	Carole Ho	Insider	Sell	3,689	$31.00	$114,359.00
6/29/2020	Douglas K Bratton	Major Shareholder	Sell	82,578	$24.01	$1,982,697.78
6/26/2020	Douglas K Bratton	Major Shareholder	Sell	122,077	$23.94	$2,922,523.38
6/22/2020	Douglas K Bratton	Major Shareholder	Sell	90,056	$24.78	$2,231,587.68
6/19/2020	Douglas K Bratton	Major Shareholder	Sell	144,920	$24.54	$3,556,336.80
6/16/2020	Marc Tessier-Lavigne	Director	Sell	400,000	$26.10	$10,440,000.00	2,739,043
3/30/2020	Alexander O Schuth	COO	Sell	1,427	$19.49	$27,812.23	28,662
3/30/2020	Ryan J Watts	CEO	Sell	4,807	$19.48	$93,640.36	22,013
3/30/2020	Steve E Krognes	CFO	Sell	1,428	$19.48	$27,817.44	1,006,488
2/26/2020	Douglas K Bratton	Major Shareholder	Sell	3,894,764	$20.25	$78,868,971.00
12/23/2019	Carole Ho	Insider	Sell	3,464	$20.01	$69,314.64
12/19/2019	Carole Ho	Insider	Sell	2,566	$20.00	$51,320.00
12/4/2019	Alexander O Schuth	COO	Sell	7,500	$18.26	$136,950.00
12/4/2019	Ryan J Watts	CEO	Sell	21,268	$18.26	$388,353.68
11/25/2019	Alexander O Schuth	COO	Sell	14,125	$18.02	$254,532.50	25,839
11/25/2019	Ryan J Watts	CEO	Sell	42,185	$18.02	$760,173.70	12,505
11/22/2019	Alexander O Schuth	COO	Sell	646	$18.00	$11,628.00	25,839
11/22/2019	Ryan J Watts	CEO	Sell	1,300	$18.00	$23,400.00	12,505
9/9/2019	Alexander O Schuth	COO	Sell	7,500	$18.16	$136,200.00
9/5/2019	Ryan J Watts	CEO	Sell	8,581	$18.05	$154,887.05	12,505
8/7/2019	Alexander O Schuth	COO	Sell	7,500	$18.81	$141,075.00
7/8/2019	Alexander O Schuth	COO	Sell	7,500	$20.28	$152,100.00
7/8/2019	Carole Ho	Insider	Sell	17,500	$20.29	$355,075.00
7/1/2019	Ryan J Watts	Insider	Sell	18,333	$20.76	$380,593.08
6/10/2019	Alexander O Schuth	COO	Sell	7,500	$18.77	$140,775.00
6/10/2019	Carole Ho	Insider	Sell	17,500	$18.78	$328,650.00
6/3/2019	Ryan J Watts	Insider	Sell	18,333	$19.07	$349,610.31

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Denali Therapeutics (NASDAQ:DNLI)

72.32% of Denali Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Denali Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/20/2022	International Biotechnology Trust PLC	38,000	$8.19M	1.8%	+46.2%	0.031%
5/20/2022	The Manufacturers Life Insurance Company	118,085	$3.82M	0.0%	+154.0%	0.096%
5/18/2022	BNP Paribas Arbitrage SA	8,243	$0.27M	0.0%	-58.2%	0.007%
5/17/2022	Walleye Capital LLC	28,296	$0.91M	0.0%	N/A	0.023%
5/17/2022	Royal Bank of Canada	8,381	$0.27M	0.0%	-9.3%	0.007%
5/17/2022	Eaton Vance Management	23,057	$0.74M	0.0%	N/A	0.019%
5/17/2022	Gilder Gagnon Howe & Co. LLC	2,619,217	$84.26M	0.8%	-9.7%	2.130%
5/17/2022	Guggenheim Capital LLC	54,427	$1.75M	0.0%	+15.8%	0.044%
5/16/2022	California State Teachers Retirement System	106,593	$3.43M	0.0%	-8.5%	0.087%
5/16/2022	Goldman Sachs Group Inc.	406,228	$13.07M	0.0%	-1.1%	0.330%
5/16/2022	PDT Partners LLC	17,850	$0.57M	0.0%	N/A	0.015%
5/16/2022	Woodline Partners LP	256,678	$8.26M	0.1%	+389.3%	0.209%
5/16/2022	State Street Corp	3,826,792	$123.11M	0.0%	+26.4%	3.113%
5/16/2022	Engineers Gate Manager LP	16,046	$0.52M	0.0%	+182.0%	0.013%
5/16/2022	Invesco Ltd.	67,634	$2.18M	0.0%	+52.1%	0.055%
5/16/2022	UBS Group AG	39,112	$1.26M	0.0%	-57.6%	0.032%
5/13/2022	Renaissance Technologies LLC	122,600	$3.94M	0.0%	+125.8%	0.100%
5/13/2022	Northern Trust Corp	906,228	$29.15M	0.0%	-5.5%	0.737%
5/13/2022	Charles Schwab Investment Management Inc.	704,251	$22.66M	0.0%	-1.8%	0.573%
5/13/2022	Wasatch Advisors Inc.	237,423	$7.64M	0.0%	+36.3%	0.193%
5/13/2022	High Net Worth Advisory Group LLC	2,000	$64K	0.0%	-20.0%	0.002%
5/13/2022	First Trust Advisors LP	14,224	$0.46M	0.0%	-6.1%	0.012%
5/13/2022	Prudential Financial Inc.	20,753	$0.67M	0.0%	-90.4%	0.017%
5/13/2022	Federated Hermes Inc.	905,245	$29.12M	0.1%	+23.1%	0.736%
5/13/2022	American International Group Inc.	45,171	$1.45M	0.0%	-6.6%	0.037%
5/13/2022	Bridgewater Associates LP	6,867	$0.22M	0.0%	N/A	0.006%
5/13/2022	Ergoteles LLC	6,693	$0.22M	0.0%	N/A	0.005%
5/13/2022	Brown Brothers Harriman & Co.	2,024	$65K	0.0%	-77.6%	0.002%
5/13/2022	Vanguard Group Inc.	8,112,030	$260.96M	0.0%	-0.6%	6.598%
5/13/2022	Allianz Asset Management GmbH	17,820	$0.57M	0.0%	-50.7%	0.014%
5/13/2022	Sei Investments Co.	10,518	$0.33M	0.0%	-7.3%	0.009%
5/13/2022	Dimensional Fund Advisors LP	878,224	$28.25M	0.0%	+13.7%	0.714%
5/12/2022	Integral Health Asset Management LLC	26,000	$0.84M	0.2%	-74.0%	0.021%
5/12/2022	Great West Life Assurance Co. Can	3,874	$0.13M	0.0%	-13.2%	0.003%
5/12/2022	BlackRock Inc.	8,185,740	$263.34M	0.0%	+0.9%	6.658%
5/12/2022	Rhumbline Advisers	97,145	$3.13M	0.0%	+0.5%	0.079%
5/12/2022	Metropolitan Life Insurance Co NY	5,579	$0.18M	0.0%	-76.8%	0.005%
5/12/2022	MetLife Investment Management LLC	50,392	$1.62M	0.0%	+55.6%	0.041%
5/12/2022	Dana Investment Advisors Inc.	11,296	$0.36M	0.0%	+17.2%	0.009%
5/12/2022	E Fund Management Co. Ltd.	8,827	$0.28M	0.0%	N/A	0.007%
5/12/2022	Eagle Asset Management Inc.	203,850	$6.56M	0.0%	+6.4%	0.166%
5/12/2022	AlphaCrest Capital Management LLC	27,200	$0.88M	0.0%	+177.2%	0.022%
5/12/2022	PNC Financial Services Group Inc.	838	$27K	0.0%	-42.3%	0.001%
5/12/2022	Citigroup Inc.	35,384	$1.14M	0.0%	-70.6%	0.029%
5/12/2022	Mitsubishi UFJ Trust & Banking Corp	314,890	$10.13M	0.0%	+1.9%	0.256%
5/11/2022	Bank of New York Mellon Corp	1,609,217	$51.77M	0.0%	+72.6%	1.309%
5/11/2022	Handelsbanken Fonder AB	11,800	$0.38M	0.0%	-34.4%	0.010%
5/11/2022	JPMorgan Chase & Co.	97,372	$3.13M	0.0%	+17.1%	0.079%
5/11/2022	GSA Capital Partners LLP	6,940	$0.22M	0.0%	+19.0%	0.006%
5/10/2022	Sectoral Asset Management Inc.	207,100	$6.66M	1.2%	+9.2%	0.168%
5/10/2022	Profund Advisors LLC	14,254	$0.46M	0.0%	-10.0%	0.012%
5/10/2022	ProShare Advisors LLC	31,881	$1.03M	0.0%	-19.1%	0.026%
5/10/2022	TD Asset Management Inc.	133,037	$4.28M	0.0%	+8.7%	0.108%
5/10/2022	Mercer Global Advisors Inc. ADV	22,915	$0.74M	0.0%	+32.1%	0.019%
5/10/2022	Ironwood Investment Management LLC	19,842	$0.64M	0.3%	+2.4%	0.016%
5/9/2022	Principal Financial Group Inc.	269,004	$8.65M	0.0%	-18.6%	0.219%
5/9/2022	Swiss National Bank	187,700	$6.04M	0.0%	+8.1%	0.153%
5/9/2022	Duality Advisers LP	34,200	$1.10M	0.1%	N/A	0.028%
5/9/2022	Teacher Retirement System of Texas	16,488	$0.53M	0.0%	+5.9%	0.013%
5/6/2022	Los Angeles Capital Management LLC	42,252	$1.36M	0.0%	+2.8%	0.034%
5/6/2022	AIA Group Ltd	41,385	$1.33M	0.1%	-61.6%	0.034%
5/5/2022	Baillie Gifford & Co.	14,980,432	$481.92M	0.3%	-0.5%	12.190%
5/5/2022	Russell Investments Group Ltd.	51,520	$1.66M	0.0%	-22.1%	0.042%
5/4/2022	Victory Capital Management Inc.	10,883	$0.26M	0.0%	-9.9%	0.009%
5/4/2022	Envestnet Asset Management Inc.	33,358	$1.07M	0.0%	+16.8%	0.027%
5/3/2022	State of New Jersey Common Pension Fund D	76,931	$2.48M	0.0%	+29.0%	0.063%
4/29/2022	SG Americas Securities LLC	8,980	$0.29M	0.0%	-72.6%	0.007%
4/29/2022	Nisa Investment Advisors LLC	2,616	$84K	0.0%	-32.1%	0.002%
4/28/2022	DekaBank Deutsche Girozentrale	59,800	$1.94M	0.0%	+9.9%	0.049%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	11,390	$0.37M	0.0%	+4.1%	0.009%
4/21/2022	Virginia Retirement Systems ET AL	14,600	$0.47M	0.0%	-43.2%	0.012%
3/9/2022	Norges Bank	846,109	$37.74M	0.0%	N/A	0.689%
3/8/2022	Bartlett & Co. LLC	16,943	$0.76M	0.0%	+1,029.5%	0.014%
2/23/2022	Barclays PLC	120,821	$5.39M	0.0%	+70.3%	0.099%
2/23/2022	BlackRock Inc.	8,110,822	$361.74M	0.0%	+7.3%	6.641%
2/19/2022	Vident Investment Advisory LLC	5,432	$0.24M	0.0%	N/A	0.004%
2/19/2022	Wells Fargo & Company MN	143,536	$6.40M	0.0%	-12.9%	0.118%
2/19/2022	Woodline Partners LP	52,454	$2.34M	0.0%	N/A	0.043%
2/17/2022	Goldman Sachs Group Inc.	410,764	$18.32M	0.0%	-61.1%	0.336%
2/16/2022	Allianz Asset Management GmbH	36,145	$1.62M	0.0%	+92.9%	0.030%
2/16/2022	The Manufacturers Life Insurance Company	46,496	$2.09M	0.0%	-0.9%	0.038%
2/16/2022	Deutsche Bank AG	118,332	$5.28M	0.0%	+2.0%	0.097%
2/16/2022	California State Teachers Retirement System	116,515	$5.20M	0.0%	+2.4%	0.095%
2/16/2022	Parametric Portfolio Associates LLC	32,444	$1.45M	0.0%	-1.7%	0.027%
2/16/2022	Wasatch Advisors Inc.	174,242	$7.77M	0.0%	-0.2%	0.143%
2/15/2022	HM Payson & Co.	578	$26K	0.0%	N/A	0.000%
2/15/2022	Sei Investments Co.	11,352	$0.50M	0.0%	-3.7%	0.009%
2/15/2022	Stifel Financial Corp	13,655	$0.61M	0.0%	-6.9%	0.011%
2/15/2022	Legal & General Group Plc	78,971	$3.52M	0.0%	+1.9%	0.065%
2/15/2022	Marshall Wace LLP	383,944	$17.12M	0.0%	-27.7%	0.314%
2/15/2022	Millennium Management LLC	18,360	$0.82M	0.0%	-56.1%	0.015%
2/15/2022	Cubist Systematic Strategies LLC	7,866	$0.35M	0.0%	-18.1%	0.006%
2/14/2022	Pier 88 Investment Partners LLC	33,080	$1.48M	0.3%	+75.2%	0.027%
2/14/2022	D. E. Shaw & Co. Inc.	7,236	$0.32M	0.0%	-84.1%	0.006%
2/14/2022	Itau Unibanco Holding S.A.	1,948	$88K	0.0%	+414.0%	0.002%
2/14/2022	Virtus ETF Advisers LLC	3,633	$0.16M	0.1%	+28.4%	0.003%
2/14/2022	Point72 Hong Kong Ltd	1,319	$59K	0.0%	+46.7%	0.001%
2/14/2022	Guggenheim Capital LLC	46,982	$2.10M	0.0%	N/A	0.038%
2/14/2022	Credit Suisse AG	1,963,648	$87.58M	0.0%	-0.9%	1.608%
2/14/2022	State Street Corp	3,027,571	$135.03M	0.0%	+8.2%	2.479%

Data available starting January 2016

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreement with Takeda Pharmaceutical Company, Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. to develop antisense therapies in the field of neurodegenerative diseases. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.

Today's Range

Now: $24.72

$23.06

$24.85

50 Day Range

MA: $28.71

$20.88

$35.19

52 Week Range

Now: $24.72

$20.24

$79.70

Volume

443,288 shs

Average Volume

660,375 shs

Market Capitalization

$3.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9

Who are the company insiders with the largest holdings of Denali Therapeutics?: Denali Therapeutics' top insider investors include:
Marc Tessier-Lavigne (Director)
David P Schenkein (Director)
Steve E Krognes (CFO)
Alexander O Schuth (COO)
Carole Ho (Insider)
Alexander O Schuth (COO)
David P Schenkein (Director)
Douglas K Bratton (Major Shareholder)
Ryan J Watts (CEO)
Steve E Krognes (CFO)
Vicki L Sato (Director)
Learn More about top insider investors at Denali Therapeutics.
Who are the major institutional investors of Denali Therapeutics?: Denali Therapeutics' top institutional shareholders include:
Baillie Gifford & Co. — 12.19%
BlackRock Inc. — 6.66%
Vanguard Group Inc. — 6.60%
State Street Corp — 3.11%
Gilder Gagnon Howe & Co. LLC — 2.13%
Bank of New York Mellon Corp — 1.31%
Learn More about top institutional investors of Denali Therapeutics stock.
Which major investors are selling Denali Therapeutics stock?: Within the previous quarter, DNLI stock was sold by these institutional investors:
Gilder Gagnon Howe & Co. LLC
Prudential Financial Inc.
Citigroup Inc.
Baillie Gifford & Co.
Integral Health Asset Management LLC
AIA Group Ltd
Principal Financial Group Inc.
UBS Group AG
During the last year, company insiders that have sold Denali Therapeutics company stock include:
Marc Tessier-Lavigne (Director)
David P Schenkein (Director)
Steve E Krognes (CFO)
Alexander O Schuth (COO)
Carole Ho (Insider)
Alexander O Schuth (COO)
Learn More investors selling Denali Therapeutics stock.
Which major investors are buying Denali Therapeutics stock?: Within the last quarter, DNLI stock was purchased by institutional investors including:
State Street Corp
Bank of New York Mellon Corp
Woodline Partners LP
Federated Hermes Inc.
Dimensional Fund Advisors LP
BlackRock Inc.
The Manufacturers Life Insurance Company
Renaissance Technologies LLC

How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.

DNLI Insider Trading (Denali Therapeutics)

Denali Therapeutics Insider Trading History Chart

Denali Therapeutics Share Price & Price History

Denali Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Denali Therapeutics (NASDAQ:DNLI)

Institutional Buying and Selling by Quarter

Denali Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Denali Therapeutics?

Who are the major institutional investors of Denali Therapeutics?

Which major investors are selling Denali Therapeutics stock?

Which major investors are buying Denali Therapeutics stock?